Company: SCLXW
Filing Date: 2025-07-23
Form Type: 424B3
Source: 0001193125-25-163077
Chunk: 231

Company: Scilex Holding Co
Filing Date: 2025-07-23
Form: 424B3
Chunk 231
---
 court or governmental authority to which Oramed is subject (including federal and state
securities laws and regulations), or by which any property or asset of Oramed is bound or affected, or (ii) result in a breach of any agreement, to which Oramed is subject or by which Oramed’s assets or properties may be subject or bound,
in each case, except for any violation or breach as would not reasonably be expected to materially impair or delay Oramed’s ability to consummate the Transactions.

(g) . Except for the representations and warranties contained in this
, neither Oramed nor any other Person makes any express or implied representation or warranty on behalf of Oramed with respect to the subject matter of this Agreement or otherwise.

4. . Purchaser hereby represents and warrants to Oramed as of the date hereof
and as of each Closing as follows:

(a) . Purchaser has all necessary corporate power and
authority required for Purchaser’s due authorization, execution, delivery and performance of this Agreement and consummation of the Transactions. This Agreement when executed and delivered by Purchaser, will be duly and validly executed and
constitute the valid and legally binding obligation of Purchaser, enforceable in accordance with its terms.

(b)
. The execution, delivery, and performance of this Agreement by Purchaser does not and will not (i) violate applicable law or rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which Purchaser is subject (including federal and state securities laws and regulations), or by which any property or asset of Purchaser is bound or affected, or (ii) result in a breach of any agreement, to which
Purchaser is subject or by which Purchaser’s assets or properties may be subject or bound, in each case, except for any violation or breach as would not reasonably be expected to materially impair or delay Purchaser’s ability to consummate
the Transactions.

(c) . Purchaser is in compliance with all applicable laws, rules and
regulations, including the rules of The Nasdaq Stock Market LLC (“”). Since April 15, 2025, Purchaser has not received any notice or communication from Nasdaq noting noncompliance with listing requirements or threatening
suspension or delisting of Common Stock from trading.

(d) . There is no litigation, investigation, or
governmental, administration, arbitral or regulatory proceeding pending or threatened in writing, against Purchaser